Trial Profile
Clinical Trials Insight: 700056965
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2010
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Irinotecan (Primary) ; Vorinostat (Primary)
- Indications Glioblastoma; Gliosarcoma
- Focus Therapeutic Use
- 15 Jun 2010 New trial record.